# Option Care Health, Inc.: overview

OPCH · Nasdaq · CIK 1014739 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/opch.md) · [Financials](/companies/opch/financials.md) · [Filings](/companies/opch/filings.md) · [Insiders](/companies/opch/insiders.md)

Latest reported revenue: [$1.35bn](/filings/0001014739-26-000011.md) for Q1 FY2026, three months to 2026-03-31, from the 10-Q filed Apr 30, 2026 (XBRL us-gaap:Revenues, accession 0001014739-26-000011).

## Last eight quarters

| Line item | Unit | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,227](/filings/0001014739-25-000037.md) | [1,279](/filings/0001014739-25-000046.md) | [1,346 d](/filings/0001014739-26-000008.md) | [1,333](/filings/0001014739-26-000011.md) | [1,416](/filings/0001014739-25-000037.md) | [1,435](/filings/0001014739-25-000046.md) | [1,465 d](/filings/0001014739-26-000008.md) | [1,351](/filings/0001014739-26-000011.md) |
| Gross margin | % | [20.3%](/filings/0001014739-25-000037.md) | [20.1%](/filings/0001014739-25-000046.md) | [19.9% d](/filings/0001014739-26-000008.md) | [19.7%](/filings/0001014739-26-000011.md) | [19.0%](/filings/0001014739-25-000037.md) | [19.0%](/filings/0001014739-25-000046.md) | [19.3% d](/filings/0001014739-26-000008.md) | [19.4%](/filings/0001014739-26-000011.md) |
| Operating margin | % | [6.6%](/filings/0001014739-25-000037.md) | [6.7%](/filings/0001014739-25-000046.md) | [6.5% d](/filings/0001014739-26-000008.md) | [5.9%](/filings/0001014739-26-000011.md) | [5.8%](/filings/0001014739-25-000037.md) | [5.9%](/filings/0001014739-25-000046.md) | [6.2% d](/filings/0001014739-26-000008.md) | [5.4%](/filings/0001014739-26-000011.md) |
| Net margin | % | [4.3%](/filings/0001014739-25-000046.md) | [4.2%](/filings/0001014739-25-000046.md) | [4.5% d](/filings/0001014739-26-000008.md) | [3.5%](/filings/0001014739-26-000011.md) | [3.6%](/filings/0001014739-25-000046.md) | [3.6%](/filings/0001014739-25-000046.md) | [4.0% d](/filings/0001014739-26-000008.md) | [3.4%](/filings/0001014739-26-000011.md) |
| Diluted EPS | $ per share | [0.30](/filings/0001014739-25-000037.md) | [0.31](/filings/0001014739-25-000046.md) | not reported | [0.28](/filings/0001014739-26-000011.md) | [0.31](/filings/0001014739-25-000037.md) | [0.32](/filings/0001014739-25-000046.md) | not reported | [0.29](/filings/0001014739-26-000011.md) |
| Free cash flow | $m | [186 d](/filings/0001014739-25-000037.md) | [151 d](/filings/0001014739-25-000046.md) | [25.8 d](/filings/0001014739-26-000008.md) | [(16.6)](/filings/0001014739-26-000011.md) | [81.2 d](/filings/0001014739-25-000037.md) | [130 d](/filings/0001014739-25-000046.md) | [22.2 d](/filings/0001014739-26-000008.md) | [(21.2)](/filings/0001014739-26-000011.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,439](/filings/0001014739-24-000009.md) | [3,869](/filings/0001014739-25-000012.md) | [4,302](/filings/0001014739-26-000008.md) | [4,998](/filings/0001014739-26-000008.md) | [5,650](/filings/0001014739-26-000008.md) |
| Gross margin | % | [22.7%](/filings/0001014739-24-000009.md) | [22.4%](/filings/0001014739-25-000012.md) | [22.8%](/filings/0001014739-26-000008.md) | [20.3%](/filings/0001014739-26-000008.md) | [19.3%](/filings/0001014739-26-000008.md) |
| Operating margin | % | [5.5%](/filings/0001014739-24-000009.md) | [6.2%](/filings/0001014739-25-000012.md) | [7.3%](/filings/0001014739-26-000008.md) | [6.4%](/filings/0001014739-26-000008.md) | [6.0%](/filings/0001014739-26-000008.md) |
| Net margin | % | [4.1%](/filings/0001014739-24-000009.md) | [3.9%](/filings/0001014739-25-000012.md) | [6.2%](/filings/0001014739-26-000008.md) | [4.2%](/filings/0001014739-26-000008.md) | [3.7%](/filings/0001014739-26-000008.md) |
| Diluted EPS | $ per share | [0.77](/filings/0001014739-24-000009.md) | [0.83](/filings/0001014739-25-000012.md) | [1.48](/filings/0001014739-26-000008.md) | [1.23](/filings/0001014739-26-000008.md) | [1.27](/filings/0001014739-26-000008.md) |
| Free cash flow | $m | [183](/filings/0001014739-24-000009.md) | [232](/filings/0001014739-25-000012.md) | [329](/filings/0001014739-26-000008.md) | [288](/filings/0001014739-26-000008.md) | [217](/filings/0001014739-26-000008.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/opch/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $463.5m | 22,104,863 |  | Added +2,217,031 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $247.1m | 11,782,384 |  | Reduced −115,083 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $173.5m | 8,274,458 |  | Added +211,903 |
| [FULLER & THALER ASSET MANAGEMENT, INC.](/funds/1082327.md) | 2026-06-30 | $156.2m | 7,450,698 |  | Added +325,418 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $148.1m | 7,063,747 |  | Added +47,424 |
| [Durable Capital Partners LP](/funds/1798849.md) | 2026-06-30 | $129.3m | 6,163,722 |  | Reduced −2,827,532 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $128.8m | 6,139,898 |  | Added +265,018 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $125.4m | 5,980,270 |  | Added +1,744,033 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $114.3m | 5,449,294 |  | Added +1,572,438 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $93.7m | 4,467,797 |  | Added +219,576 |

## Recent filings

[All 1,372 filings](/companies/opch/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 08:22 ET | [8-K](/filings/0001104659-26-113904.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-113904 |
| 2026-07-29 | 07:26 ET | [10-Q](/filings/0001014739-26-000023.md) | Quarterly report, period 2026-06-30 | 0001014739-26-000023 |
| 2026-07-29 | 06:56 ET | [8-K](/filings/0001014739-26-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-26-000021 |
| 2026-05-22 | 16:00 ET | [8-K](/filings/0001014739-26-000017.md) | 5.07 Shareholder vote results | 0001014739-26-000017 |
| 2026-05-12 | 07:00 ET | [8-K](/filings/0001104659-26-058979.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-058979 |
| 2026-05-05 | 16:01 ET | [8-K](/filings/0001014739-26-000014.md) | 5.02 Departure or appointment of officers or directors | 0001014739-26-000014 |
| 2026-04-30 | 16:00 ET | [10-Q](/filings/0001014739-26-000011.md) | Quarterly report, period 2026-03-31 | 0001014739-26-000011 |
| 2026-04-30 | 07:01 ET | [8-K](/filings/0001104659-26-052099.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-052099 |
| 2026-04-08 | 16:15 ET | [DEF 14A](/filings/0001140361-26-013825.md) | Proxy statement, period 2026-05-20 | 0001140361-26-013825 |
| 2026-04-02 | 16:15 ET | [8-K](/filings/0001104659-26-039171.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-039171 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001014739-26-000008.md), filed Feb 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1014739
- Tickers: OPCH
- Exchange: Nasdaq
- SIC code: 8082 Services-Home Health Care Services
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:18 ET. No prices; not investment advice.